Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

IGF-IR mediated mammary tumorigenesis is enhanced during pubertal development.

Jones RA, Watson KL, Campbell CI, Moorehead RA.

PLoS One. 2014 Sep 26;9(9):e108781. doi: 10.1371/journal.pone.0108781. eCollection 2014.

2.

Do patient-perceived pros and cons of opioids predict sustained higher-dose use?

Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell CI, Weisner CC, Korff MV.

Clin J Pain. 2014 Feb;30(2):93-101. doi: 10.1097/AJP.0b013e31828e361b.

3.

12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity.

Chi FW, Sterling S, Campbell CI, Weisner C.

Subst Abus. 2013;34(1):33-42. doi: 10.1080/08897077.2012.691780.

4.

Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients.

Merrill JO, Von Korff M, Banta-Green CJ, Sullivan MD, Saunders KW, Campbell CI, Weisner C.

Gen Hosp Psychiatry. 2012 Nov-Dec;34(6):581-7. doi: 10.1016/j.genhosppsych.2012.06.018. Epub 2012 Sep 5.

5.

Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.

Grattan A, Sullivan MD, Saunders KW, Campbell CI, Von Korff MR.

Ann Fam Med. 2012 Jul-Aug;10(4):304-11. doi: 10.1370/afm.1371.

6.

Depression and ambivalence toward chronic opioid therapy for chronic noncancer pain.

Howe CQ, Sullivan MD, Saunders KW, Merrill JO, Banta-Green CJ, Weisner C, Campbell CI, Von Korff M.

Clin J Pain. 2012 Sep;28(7):561-6. doi: 10.1097/AJP.0b013e31823ade59.

7.

12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment.

Mundt MP, Parthasarathy S, Chi FW, Sterling S, Campbell CI.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):124-30. doi: 10.1016/j.drugalcdep.2012.05.002. Epub 2012 May 26.

8.

Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.

Saunders KW, Von Korff M, Campbell CI, Banta-Green CJ, Sullivan MD, Merrill JO, Weisner C.

J Pain. 2012 Mar;13(3):266-75. doi: 10.1016/j.jpain.2011.11.004. Epub 2012 Jan 29.

9.

Twelve-Step attendance trajectories over 7 years among adolescents entering substance use treatment in an integrated health plan.

Chi FW, Campbell CI, Sterling S, Weisner C.

Addiction. 2012 May;107(5):933-42. doi: 10.1111/j.1360-0443.2011.03758.x. Epub 2012 Feb 11.

10.
11.

Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature.

Franks SE, Campbell CI, Barnett EF, Siwicky MD, Livingstone J, Cory S, Moorehead RA.

Oncogene. 2012 Jul 5;31(27):3298-309. doi: 10.1038/onc.2011.486. Epub 2011 Oct 24.

12.

Murine mammary tumor cells with a claudin-low genotype.

Campbell CI, Thompson DE, Siwicky MD, Moorehead RA.

Cancer Cell Int. 2011 Aug 16;11:28. doi: 10.1186/1475-2867-11-28.

13.

Prescription long-term opioid use in HIV-infected patients.

Silverberg MJ, Ray GT, Saunders K, Rutter CM, Campbell CI, Merrill JO, Sullivan MD, Banta-Green CJ, Von Korff M, Weisner C.

Clin J Pain. 2012 Jan;28(1):39-46. doi: 10.1097/AJP.0b013e3182201a0f.

14.

Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy.

Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C.

Pain. 2011 Jun;152(6):1256-62. doi: 10.1016/j.pain.2011.01.005. Epub 2011 Feb 5.

15.
16.

Age and gender trends in long-term opioid analgesic use for noncancer pain.

Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, Banta-Green CJ, Merrill JO, Silverberg MJ, Boudreau D, Satre DD, Von Korff M.

Am J Public Health. 2010 Dec;100(12):2541-7. doi: 10.2105/AJPH.2009.180646. Epub 2010 Aug 19.

17.

Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan.

Satre DD, Campbell CI, Gordon NS, Weisner C.

Int J Psychiatry Med. 2010;40(1):57-76.

18.

Opioid prescriptions for chronic pain and overdose: a cohort study.

Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M.

Ann Intern Med. 2010 Jan 19;152(2):85-92. doi: 10.7326/0003-4819-152-2-201001190-00006.

19.

Trends in long-term opioid therapy for chronic non-cancer pain.

Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1166-75. doi: 10.1002/pds.1833.

20.

Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders.

Weisner CM, Campbell CI, Ray GT, Saunders K, Merrill JO, Banta-Green C, Sullivan MD, Silverberg MJ, Mertens JR, Boudreau D, Von Korff M.

Pain. 2009 Oct;145(3):287-93. doi: 10.1016/j.pain.2009.05.006. Epub 2009 Jul 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk